摘要
目的观察通络益肾汤对链脲佐菌素(STZ)糖尿病肾病大鼠的疗效,探讨其可能的作用机理。方法采用STZ糖尿病肾病大鼠模型,分为正常组、病理组、通络益肾汤治疗组、西药治疗组(糖适平+洛汀新)。观察各组大鼠治疗前后血糖、血脂、肾功能(BUN、Scr)、血浆蛋白、血浆NO等指标的变化。结果与病理组比较,通络益肾汤治疗组大鼠一般状况改善较好,血糖升高不明显(P<0.05),血清BUN、Scr显著降低(P<0.01)、TG、TC降低,HDL升高,(P<0.01或P<0.05)。血浆NO含量明显升高(P<0.01)。通络益肾汤治疗组与西药组比较,各项指标无明显差异。结论通络益肾汤能延缓糖尿病肾病的病理进展,其作用机理可能与升高血浆NO水平有关。
Objective To observe the effects and the mechanism of Tong- Luo- Yi -Shen- Tang(TLYST) on the streptczotcin (STZ) -induced diabetic nephropathy rats. Methods The diabetic nephropathy animal model was induced by luing STZ. Rats were divided into normal group ( A group), model group ( B group), TLYST treatment group ( C group), Gliquidon and Lotensin control guoup( D group). Blood glucose levels, blood urea nitrogen ( BUN ), serum creatinine ( Scr), triglyceride ( TG ), cholestrol (CHO) ,high- density liprutein(HDL) and nitric oxide were measured. Results Compared with model group , blood glucose, BUN,Scr,TG,CHO decreased in C group (P 〈0.05 or P 〈0.01 ), nitric oxide,HDL were significantly improved ( P 〈 0.01 ) . Condusion TLYST could relieve and retard the progress of DN, It's mechanism may be correlating with increased the content of NO.
出处
《时珍国医国药》
CAS
CSCD
北大核心
2006年第8期1399-1400,共2页
Lishizhen Medicine and Materia Medica Research
基金
陕西省中医管理局资助项目(NO.2003107)
关键词
通络益肾汤
糖尿病肾病
一氧化氮
糖尿病肾病大鼠模型
Tong-Luo-Yi-Shen-Tang
Diabetic nephropathy
Nitric Oxide
Diabetic nephropathy animal model